Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q30268745)
Watch
English
AC Immune
expertise in the understanding and treatment of neurodegeneration
In more languages
edit
Statements
instance of
business
1 reference
stated in
GRID Release 2017-05-22
inception
13 February 2003
3 references
stated in
GRID Release 2017-05-22
stated in
ROR release v1.19
reference URL
https://prestations.vd.ch/pub/101266/
country
Switzerland
1 reference
stated in
GRID Release 2017-05-22
headquarters location
Lausanne
coordinate location
46°31'4.008"N, 6°33'42.851"E
1 reference
GRID ID
grid.476060.3
stock exchange
Nasdaq
start time
13 September 2016
1 reference
reference URL
https://www.nasdaq.com/articles/alzheimers-biotech-ac-immune-sets-terms-55-million-ipo-2016-09-13
official website
http://www.acimmune.com/
1 reference
stated in
GRID Release 2017-05-22
Identifiers
VIAF ID
1293145857124022922469
0 references
ISNI
0000000477029629
1 reference
ROR ID
00e8cky09
Crunchbase organization ID
ac-immune-sa
0 references
GRID ID
grid.476060.3
1 reference
stated in
GRID Release 2017-05-22
Ringgold ID
548402
subject named as
AC Immune SA
0 references
ROR ID
00e8cky09
0 references
Sitelinks
Wikipedia
(1 entry)
edit
frwiki
AC Immune
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit